中国中药协会在前述7月8日的发文中提到，对药材市场行情尤其是所需采购药材品种的市场行情等进行密切跟踪，及时调整中药饮片和中成药生产计划。同时，建议大中型企业尤其是品牌、优质企业应率先行动，打造中药全产业链质量管控体系，建立中药材质量追溯体系，促进产销直接对接，尽量减少中间炒作环节。

zhongguodangxiadejichuyanjiuyi“zhongyangcaizhengzhichi”weizhu，qitedianshikeyanrenyuanzhuyaotongguoxiangmujingzhengdefangshihuoqu，zhexiexiangmufenbuzaikejibu、jijinweidengbutongkeyanguanlijigouzhong，meileixiangmuduiyingbutongdezizhueduhezhouqi，xiangmupingshenyeyouzhengfujigouzuzhilinshixingdezhuanjiaweiyuanhuijinxing，zhezhongjingzhengshiquanguofanweineideyouzhongyouxuan。中(zhong)国(guo)当(dang)下(xia)的(de)基(ji)础(chu)研(yan)究(jiu)以(yi)“(“)中(zhong)央(yang)财(cai)政(zheng)支(zhi)持(chi)”(”)为(wei)主(zhu)，(，)其(qi)特(te)点(dian)是(shi)科(ke)研(yan)人(ren)员(yuan)主(zhu)要(yao)通(tong)过(guo)项(xiang)目(mu)竞(jing)争(zheng)的(de)方(fang)式(shi)获(huo)取(qu)，(，)这(zhe)些(xie)项(xiang)目(mu)分(fen)布(bu)在(zai)科(ke)技(ji)部(bu)、(、)基(ji)金(jin)委(wei)等(deng)不(bu)同(tong)科(ke)研(yan)管(guan)理(li)机(ji)构(gou)中(zhong)，(，)每(mei)类(lei)项(xiang)目(mu)对(dui)应(ying)不(bu)同(tong)的(de)资(zi)助(zhu)额(e)度(du)和(he)周(zhou)期(qi)，(，)项(xiang)目(mu)评(ping)审(shen)也(ye)由(you)政(zheng)府(fu)机(ji)构(gou)组(zu)织(zhi)临(lin)时(shi)性(xing)的(de)专(zhuan)家(jia)委(wei)员(yuan)会(hui)进(jin)行(xing)，(，)这(zhe)种(zhong)竞(jing)争(zheng)是(shi)全(quan)国(guo)范(fan)围(wei)内(nei)的(de)优(you)中(zhong)优(you)选(xuan)。(。)